September 25, 2024
KPMG HQ
Chicago, Ill
8:00AM
REGISTRATION, CONTINENTAL BREAKFAST & NETWORKING
Welcome to Chicago – Introductions
Speaker:
Don Buford, Founder & CEO,
iiBIG LLC – New York
9:05AM
KEYNOTE ADDRESS
Artificial Intelligence & Healthcare: Legislative & Regulatory Outlook
Honorable Bill Foster (IL-11)*
United States House of Representatives,
Member of the Bipartisan House Task Force on Artificial Intelligence
(Via Zoom from Washington, DC)
9:35AM
PART I: State of Healthcare and Life Sciences M&A Industry
After an uncertain 2023, 2024 has started with strength. Life sciences, including pharma, diagnostics, devices, and life sciences tools and services, are growing and shaping to serve more complex ecosystems, and healthcare is starting to recover with more attention to shedding distressed units or units better operated in other systems. KPMG will highlight the state of the state to kick off our day of sharing on tactical challenges and best practices in organic and inorganic growth and innovation in the healthcare and life sciences markets.
SPONSORED BY: 
Moderator:
-
Kristin Pothier, Global and US Healthcare and Life Sciences Deal Advisory and Strategy Leader, KPMG – Boston, MA
10:40AM
AM NETWORKING BREAK, REFRESHMENTS & INFORMAL DISCUSSIONS
Investing for the Future:
The Convergence of Artificial Intelligence, Healthcare & Life Sciences
AI is rapidly becoming an elevated topic of conversation in our healthcare and life sciences ecosystem. On this panel, HCLS AI leaders will discuss the hope and hype of AI and will highlight other areas having equally profound impact.
- What do HCLS investors need to understand about the 12- to 18-months ahead before investing in AI-based companies?
- Is it too early to discern hype from reality? Is there compelling evidence yet that AI is truly affecting clinical outcomes?
-
How can AI enhance the value and efficiency of middle-market Healthcare & Life Science Organizations when seeking funding or acquisitions?
Moderator:
- Kristin Pothier, Global and US Healthcare and Life Sciences Deal Advisory and Strategy Leader, KPMG – Boston, MA
Panelists:
- Ivneet Bhullar, Investment Partner,
Fusion Fund – Palo Alto, CA - Eric Horler, President & CEO,
AIQ Solutions – Madison, WI - Doug King, CIO & SVP, Information Services,
Northwestern Memorial Healthcare – Chicago, IL - Imran Shaikh, Chief Technology Officer,
Shore Capital Partners – Chicago, IL
12:00PM
LUNCHEON FOR ALL CONFERENCE PARTICIPANTS
LUNCHEON ADDRESS: “Navigating the Minefield of Insurance & Risk in Healthcare & Life Sciences”
SPONSORED BY:
Speakers:
- Matthew Cohn, SVP, Team leader, Healthcare & Life Sciences, Alliant Insurance Services, Inc.
1:00PM
Restart and Refresh: The New Investments of 2024
Investing in healthcare and life sciences in 2024 has required a new resolve and realization that the ecosystem, IP, competition, and risk appetite for innovation has changed. This session brings together business development executives in Life Sciences and Healthcare to discuss their POV on the sectors that are showing the most promise in 2024/25.
Moderator:
- Thomas E. (Ted) Keim, Jr., Partner,
Venable LLP – Chicago, IL
Panelists:
- Kyle Brown, Managing Director,
Brown Gibbons Lang & Co. – Chicago, IL - Sebastien Dhonte, Managing Director,
Clairvest – Toronto, ON CA - David Michael, Managing Partner,
Anzu Partners LLC – San Diego, CA
1:55PM
PART II: ITS ONLY JUST BEGUN
Executing Complex Transactions in an Evolving Market.
HCLS M&A has had a turbulent ride over the last few years and the turbulence does not stop once the deal is announced. Rather, management teams, already exhausted with drawn out or extra competitive diligence processes, now need to integrate or separate assets with new savvy. This session will highlight the best demonstrated practices, lessons learned and predictions for the second half of 2024.
Moderator:
- Steve Sapletal, Global and US Transaction Execution Leader, KPMG – Minneapolis, MN
Panelists:
- Evan Atkinson, Senior Attorney, Dykema – Austin, TX
- Ryan Boers, COO – Business Development & Strategy, GE Healthcare – Chicago, IL
- Jenifer Christensen, VP, Strategic Initiatives, AbbVie – Chicago, IL
- Chad Follmer, SVP, Team Leader, Healthcare & Life Sciences, Alliant Insurance Services, Inc.
2:45PM
PM NETWORKING BREAK, REFRESHMENTS & INFORMAL DISCUSSIONS
3:15PM
TRY IT BEFORE YOU BUY IT: Partnerships & Joint Ventures Roundtable
- When does it make more sense to form joint venture and partnership relationships than to execute outright mergers or acquisitions?
- Hybrid Partnerships: When are Minority Investments Preferable vs. Full Acquisitions?
- How are these partnerships and joint-venture deals being structured?
- How are interest rate pressures affecting the decisions to enter into partnerships and joint ventures vs. traditional M&A deals?
Moderator:
- Ari Markenson, Partner,
Venable LLP – New York, NY
Panelists:
- Chaz Bauer, Director, Healthcare Investment Banking, Fifth Third Securities – Chicago, IL
- Adam Davis, Vice President,
Juniper Advisory – Chicago, IL - Rahil Manji, VP,
Clairvest – Toronto, ON CA
4:10PM
PART III: HOW WE INVEST
Born in Turbulence: Current Investing and Acquisition Tactics in Healthcare & Life Sciences
The last few years have not been the most amenable to investing in or acquiring young companies. In this session, we will highlight the following major questions:
- How are PE, VC and other Private Investors Sizing up Opportunities in 2024-25?
- How are Traditional & Specialty Lenders approaching Potential Deal-flow in these Sectors in the Year Ahead?
- How is PE adjusting to the aggressiveness of strategic investors?
- What are the best demonstrated diligence practices in this new normal?
Moderator:
- Brett Glover, HCLS Deal Advisory Leader,
KPMG – Dallas, TX
Panelists:
- Steve Lehmann, MBA, Director of Venture Operations, Portal Innovations – Chicago, IL
- Tommy Ryan, Managing Director, Originations,
Deerpath Capital – Chicago, IL - Mark Thornton, Executive Advisor, Iron Path Capital and CEO, VION Biosciences – Nashville, TN
5:00PM
Conference Sessions Concludes
5:00 – 6:00PM
Evening Networking Reception
CONTINUING EDUCATION CREDITS
Continuing Education Credits (e.g. CLE, CPE, CME, etc.) may be available for iiBIG conference attendees. Upon request conference attendees will be provided with a “Certificate of Attendance” and a copy of the conference agenda, showing topics, length of sessions, and name(s) and professional affiliation(s) of presenter(s) for each session. Attendees wishing to apply for continuing education credits for attending this conference may submit this documentation to the relevant organization in his/her state when applying for such credits.
International Institute for Business Information & Growth LLC is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org.